| Financial Year |
March 31 2023 |
| Monetary Funds |
227,258,387.34 |
| Held-for-trading Financial Assets |
60,000,000.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
114,677,592.64 |
| Advances to Suppliers |
10,990,419.81 |
| Other Receivables |
60,002,792.50 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
75,780,150.84 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
4,539,175.35 |
| Total Current Assets |
553,248,518.48 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
806,042,499.93 |
| Under-construction Projects |
292,525,008.23 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
48,889,490.10 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
2,613,333.32 |
| Deferred Income Tax Assets |
12,215,405.76 |
| Other Non-Current Assets |
9,360,238.09 |
| Sub-Total of Non-Current Assets |
1,174,598,577.31 |
| Total Assets |
1,727,847,095.79 |
| Short-Term Loans |
230,306,034.11 |
| Trading Financial liabilities |
-- |
| Notes Payable |
30,000,000.00 |
| Accounts Payable |
84,186,336.13 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
27,415,053.97 |
| Taxes Payable |
5,993,122.70 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
36,445,233.50 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
55,261,136.18 |
| Other Current Liabilities |
475,130.94 |
| Sub-Total of Current Liabilities |
474,194,201.73 |
| Long-term Loans |
114,057,240.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
65,716,270.20 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
208,117,327.95 |
| Total Liabilities |
682,311,529.68 |
| Paid-In Capital(Or Share Stock) |
124,780,000.00 |
| Capital Surplus |
526,961,762.97 |
| Surplus Reserve |
31,244,431.85 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
362,216,160.70 |
| Minority Stockholder's Interest |
333,210.59 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,045,202,355.52 |
| Owner's Equity（Stockholder's Equity） |
1,045,535,566.11 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,727,847,095.79 |
